AmCad BioMed Corporation (TPEX:4188)
Taiwan · Delayed Price · Currency is TWD 15.25
+0.25 (1.67%)
Aug 29, 2025, 1:30 PM CST
AmCad BioMed Market Cap
AmCad BioMed has a market cap or net worth of 965.83 million as of August 29, 2025. Its market cap has decreased by -26.31% in one year.
Market Cap
965.83M
Enterprise Value
667.39M
Revenue
43.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.25
Market Cap Chart
Since December 26, 2013, AmCad BioMed's market cap has increased from 905.63M to 965.83M, an increase of 6.65%. That is a compound annual growth rate of 0.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 965.83M | -31.77% |
| Dec 31, 2024 | 1.42B | -0.45% |
| Dec 29, 2023 | 1.42B | 67.51% |
| Dec 30, 2022 | 848.88M | -17.57% |
| Dec 30, 2021 | 1.03B | 0.26% |
| Dec 31, 2020 | 1.03B | -19.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 313.31B |
| PharmaEssentia | 165.47B |
| Bora Pharmaceuticals Co., LTD. | 90.22B |
| Lotus Pharmaceutical | 50.89B |
| Oneness Biotech | 33.48B |
| Lumosa Therapeutics | 32.18B |
| Polaris Group | 30.09B |
| Center Laboratories | 26.50B |